Article

CMS decision allows beneficiary access to toric IOL

Baltimore-Medicare beneficiaries undergoing cataract surgery now have the option of choosing a toric IOL instead of a conventional lens following a ruling by the Centers for Medicare and Medicaid Services (CMS).

Baltimore-Medicare beneficiaries undergoing cataract surgery now have the option of choosing a toric IOL instead of a conventional lens following a ruling by the Centers for Medicare and Medicaid Services (CMS).

Those beneficiaries opting to receive the astigmatism-correcting implant will be responsible for paying the difference between the cost of that IOL and Medicare’s reimbursement as well as the additional cost associated with insertion of the toric lens.

The ruling took effect Jan. 22 and is available at

www.cms.hhs.gov/rulings/downloads/CMS1536R.pdf.

CMS will provide additional guidance, including a list of the specific IOLs affected, to Medicare contractors.


Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.